ALB
Albemarle Corporation
$118.72
▲ +0.92%
+$1.08
NYSE · Basic Materials · Specialty Chemicals
· price updated 9h ago
Albemarle Corporation
ALB · NYSE · Basic Materials · Specialty Chemicals · price updated 9h ago
$118.72
▲ +0.92% · +$1.08 today
AI research · $118.72
Track ALB for continuous AI research
price position
Where ALB sits now
52-week range
Low$64.95
High$221.00
Today $118.72
RSI (14)
27.2Oversold
03070100
fundamentals
Business quality and valuation
Operating record
What the business has actually produced
Revenue
Capital structure
Cash versus debt
Cash & investments$1.1B
Total debt$1.9B
Net cash after debt$-792.0M
Valuation
What the market charges
Forward P/E
Price against expected earnings
Favorable · 22% below Sector avg · favorable
8.56x
Price / sales
Value assigned to each sales dollar
Strong · Under 3x annual sales
2.53x
Price / FCF
Price against free cash generation
Reasonable · Between 20x and 35x free cash flow
24.11x
EV / EBITDA
Operating value including debt
Rich · Above 22x EBITDA
29.50x
Quality
How efficiently it compounds
ROIC
Return earned on invested capital
Weak · Below 8% return on capital
3.7%
ROE
Profit generated from shareholder equity
Needs attention · Among weakest in sector
-1.8%
Debt / equity
Balance-sheet leverage
Favorable · Exceptional vs sector peers
0.20x
Current ratio
Short-term assets against liabilities
Strong · Comfortable short-term liquidity
2.07x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
peer comparison
How ALB compares
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $13.87B | - | +7.9% | 62 |
 | $98.74B | 11.8 | +25.2% | 83 |
 | $9.47B | 20.3 | +66.3% | 81 |
 | $4.43B | 13.4 | +7.5% | 76 |
 | $90.03B | 30.8 | +0.2% | 70 |
US stock research
About Albemarle Corporation (ALB) stock
Albemarle Corporation — US core universe (S&P 500 sourced). ALB was +0.9% in the latest available session at $118.72. Its reported market value was $13.87B with a trailing P/E of 0.0. Latest reported revenue was $5.50B, changing +7.9% year over year, with $-399.64M in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.
- Latest available price
- $118.72
- Day change
- +0.9%
- Market cap
- $13.87B
- P/E (TTM)
- 0.0
- Revenue growth
- +7.9%
- Industry
- Specialty Chemicals